DUE DILIGENCE PROJECTS, FIRST-IN-HUMAN/FIRST-IN-PLATFORM CLINICAL TRIALS DESIGN AND CONDUCT, FRACTIONAL CMO SUPPORT

Leverage Our Expertise to Your Specific Needs

Expert strategic and tactical services for: early drug development in oncology, rare diseases, gene editing and complicated clinical pharmacology challenges.

Two scientists in a laboratory, both wearing white lab coats and protective eyewear. The scientist in the foreground is using a pipette, while the one in the background is working on a computer. Various laboratory equipment and supplies are visible around them.
Two scientists in a laboratory, both wearing white lab coats and protective eyewear. The scientist in the foreground is using a pipette, while the one in the background is working on a computer. Various laboratory equipment and supplies are visible around them.
ONCOLOGY SERVICES

We bring special expertise in First-in-Human and First-in-Platform Phase 1 studies. We can provide limited services focused on the dose escalation plan or extensive services including fractional CMO overseeing development of IND, Protocol, CRO and site selection, and efficient execution of dose escalation decisions and study completion.

GENE EDITING SERVICES

We can capably bring the same options to your rare disease- or oncology-oriented gene editing projects.

DUE DILIGENCE AND STRATEGIC ASSESSMENTS

Short term research and evaluation projects for start-up Biotechs and Venture Capital firms to evaluate entity acquisitions or revise portfolios.